251 related articles for article (PubMed ID: 28714365)
1. Conjugation of gold nanoparticles and recombinant human endostatin modulates vascular normalization via interruption of anterior gradient 2-mediated angiogenesis.
Pan F; Yang W; Li W; Yang XY; Liu S; Li X; Zhao X; Ding H; Qin L; Pan Y
Tumour Biol; 2017 Jul; 39(7):1010428317708547. PubMed ID: 28714365
[TBL] [Abstract][Full Text] [Related]
2. Extension of the in vivo half-life of endostatin and its improved anti-tumor activities upon fusion to a humanized antibody against tumor-associated glycoprotein 72 in a mouse model of human colorectal carcinoma.
Lee SH; Jeung IC; Park TW; Lee K; Lee DG; Cho YL; Lee TS; Na HJ; Park YJ; Lee HG; Jeong MS; Bae KH; Lee SC; Lee HJ; Kwon YG; Hong HJ; Kim JS; Min JK
Oncotarget; 2015 Mar; 6(9):7182-94. PubMed ID: 25762629
[TBL] [Abstract][Full Text] [Related]
3. Gold Nanoparticle-Mediated Targeted Delivery of Recombinant Human Endostatin Normalizes Tumour Vasculature and Improves Cancer Therapy.
Li W; Zhao X; Du B; Li X; Liu S; Yang XY; Ding H; Yang W; Pan F; Wu X; Qin L; Pan Y
Sci Rep; 2016 Jul; 6():30619. PubMed ID: 27470938
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human endostatin combined with radiotherapy inhibits colorectal cancer growth.
Zhang K; Wang Y; Yu X; Shi Y; Yao Y; Wei X; Ma X
BMC Cancer; 2017 Dec; 17(1):899. PubMed ID: 29282026
[TBL] [Abstract][Full Text] [Related]
5. Sorafenib derivatives-functionalized gold nanoparticles confer protection against tumor angiogenesis and proliferation via suppression of EGFR and VEGFR-2.
Huang W; Xing Y; Zhu L; Zhuo J; Cai M
Exp Cell Res; 2021 Sep; 406(1):112633. PubMed ID: 34089726
[TBL] [Abstract][Full Text] [Related]
6. Anti-angiogenic effects of a mutant endostatin: a new prospect for treating retinal and choroidal neovascularization.
Bai Y; Zhao M; Zhang C; Li S; Qi Y; Wang B; Huang L; Li X
PLoS One; 2014; 9(11):e112448. PubMed ID: 25380141
[TBL] [Abstract][Full Text] [Related]
7. Control of angiogenesis by VEGF and endostatin-encapsulated protein microcrystals and inhibition of tumor angiogenesis.
Matsumoto G; Hirohata R; Hayashi K; Sugimoto Y; Kotani E; Shimabukuro J; Hirano T; Nakajima Y; Kawamata S; Mori H
Biomaterials; 2014 Jan; 35(4):1326-33. PubMed ID: 24210874
[TBL] [Abstract][Full Text] [Related]
8. Endostatin suppresses colorectal tumor-induced lymphangiogenesis by inhibiting expression of fibronectin extra domain A and integrin α9.
Ou J; Li J; Pan F; Xie G; Zhou Q; Huang H; Liang H
J Cell Biochem; 2011 Aug; 112(8):2106-14. PubMed ID: 21465533
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Vasculogenic Mimicry and Angiogenesis by an Anti-EGFR IgG1-Human Endostatin-P125A Fusion Protein Reduces Triple Negative Breast Cancer Metastases.
Shin SU; Cho HM; Das R; Gil-Henn H; Ramakrishnan S; Al Bayati A; Carroll SF; Zhang Y; Sankar AP; Elledge C; Pimentel A; Blonska M; Rosenblatt JD
Cells; 2021 Oct; 10(11):. PubMed ID: 34831127
[TBL] [Abstract][Full Text] [Related]
10. Oleanolic Acid Inhibits Colorectal Cancer Angiogenesis by Blocking the VEGFR2 Signaling Pathway.
Niu G; Sun L; Pei Y; Wang D
Anticancer Agents Med Chem; 2018; 18(4):583-590. PubMed ID: 29065844
[TBL] [Abstract][Full Text] [Related]
11. Effects of recombinant human endostatin and its synergy with cisplatin on circulating endothelial cells and tumor vascular normalization in A549 xenograft murine model.
Li N; Zheng D; Wei X; Jin Z; Zhang C; Li K
J Cancer Res Clin Oncol; 2012 Jul; 138(7):1131-44. PubMed ID: 22402599
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of recombinant human endostatin and docetaxel on human umbilical vein endothelial cells in different growth states.
Xu WJ; Huang C; Wang J; Jiang RC; Wang LC; Lin L; Liu ZJ; Sun BC; Li K
Chin Med J (Engl); 2011 Sep; 124(18):2883-9. PubMed ID: 22040497
[TBL] [Abstract][Full Text] [Related]
13. Anti-angiogenic activity of human endostatin is HIF-1-independent in vitro and sensitive to timing of treatment in a human saphenous vein assay.
Macpherson GR; Ng SS; Forbes SL; Melillo G; Karpova T; McNally J; Conrads TP; Veenstra TD; Martinez A; Cuttitta F; Price DK; Figg WD
Mol Cancer Ther; 2003 Sep; 2(9):845-54. PubMed ID: 14555703
[TBL] [Abstract][Full Text] [Related]
14. Effect of recombinant human endostatin on the expression of c-Myc and bFGF in mouse gastric cancer cells.
Guo ZY; Yao GD; Fu LP; Fu ZG; Hou B
Genet Mol Res; 2015 May; 14(2):5258-65. PubMed ID: 26125720
[TBL] [Abstract][Full Text] [Related]
15. GX1-conjugated poly(lactic acid) nanoparticles encapsulating Endostar for improved in vivo anticolorectal cancer treatment.
Du Y; Zhang Q; Jing L; Liang X; Chi C; Li Y; Yang X; Dai Z; Tian J
Int J Nanomedicine; 2015; 10():3791-802. PubMed ID: 26060399
[TBL] [Abstract][Full Text] [Related]
16. Simulation of tumor-induced angiogenesis and its response to anti-angiogenic drug treatment: mode of drug delivery and clearance rate dependencies.
Tee D; DiStefano J
J Cancer Res Clin Oncol; 2004 Jan; 130(1):15-24. PubMed ID: 14586644
[TBL] [Abstract][Full Text] [Related]
17. Tat PTD-Endostatin-RGD: A novel protein with anti-angiogenesis effect in retina via eye drops.
Li Y; Li L; Li Z; Sheng J; Zhang X; Feng D; Zhang X; Yin F; Wang A; Wang F
Biochim Biophys Acta; 2016 Oct; 1860(10):2137-47. PubMed ID: 27233450
[TBL] [Abstract][Full Text] [Related]
18. Sp1 inhibition-mediated upregulation of VEGF 165 b induced by rh-endostatin enhances antiangiogenic and anticancer effect of rh-endostatin in A549.
Li ZY; Zhu F; Hu JL; Peng G; Chen J; Zhang S; Chen X; Zhang RG; Chen LJ; Liu P; Luo M; Sun ZH; Ren JH; Huang LL; Wu G
Tumour Biol; 2011 Aug; 32(4):677-87. PubMed ID: 21442281
[TBL] [Abstract][Full Text] [Related]
19. Adeno-associated virus-mediated antiangiogenic gene therapy with thrombospondin-1 type 1 repeats and endostatin.
Zhang X; Xu J; Lawler J; Terwilliger E; Parangi S
Clin Cancer Res; 2007 Jul; 13(13):3968-76. PubMed ID: 17606731
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human endostatin enhances the radioresponse in esophageal squamous cell carcinoma by normalizing tumor vasculature and reducing hypoxia.
Zhu H; Yang X; Ding Y; Liu J; Lu J; Zhan L; Qin Q; Zhang H; Chen X; Yang Y; Yang Y; Liu Z; Yang M; Zhou X; Cheng H; Sun X
Sci Rep; 2015 Sep; 5():14503. PubMed ID: 26412785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
